BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11307940)

  • 21. Antimicrobial susceptibilities and resistance genes of Canadian isolates of Actinobacillus pleuropneumoniae.
    Archambault M; Harel J; Gouré J; Tremblay YD; Jacques M
    Microb Drug Resist; 2012 Apr; 18(2):198-206. PubMed ID: 22204596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCR-based identification of serotype 2 isolates of Actinobacillus pleuropneumoniae biovars I and II.
    Hüssy D; Schlatter Y; Miserez R; Inzana T; Frey J
    Vet Microbiol; 2004 Apr; 99(3-4):307-10. PubMed ID: 15066734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the susceptibility of Actinobacillus pleuropneumoniae to antimicrobial agents in Quebec (1981-1986).
    Vaillancourt JP; Higgins R; Martineau GP; Mittal KR; Larivière S
    J Am Vet Med Assoc; 1988 Aug; 193(4):470-3. PubMed ID: 3170322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleuropneumonia in swine associated with a urease-negative variant of Actinobacillus pleuropneumoniae serotype 1.
    Blanchard PC; Walker RL; Gardner I
    J Vet Diagn Invest; 1993 Apr; 5(2):279-82. PubMed ID: 8507708
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of serology, bacteriological isolation and polymerase chain reaction for the detection of pigs carrying Actinobacillus pleuropneumoniae in the upper respiratory tract after experimental infection.
    Chiers K; Donné E; Van Overbeke I; Ducatelle R; Haesebrouck F
    Vet Microbiol; 2002 Sep; 88(4):385-92. PubMed ID: 12220813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
    Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
    Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
    Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
    BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae.
    Yoshimura H; Takagi M; Ishimura M; Endoh YS
    Vet Res Commun; 2002 Jan; 26(1):11-9. PubMed ID: 11860083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine.
    Chang CF; Chang LC; Chang YF; Chen M; Chiang TS
    J Vet Diagn Invest; 2002 Mar; 14(2):153-7. PubMed ID: 11939337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of tulathromycin in the treatment of respiratory disease in pigs caused by Actinobacillus pleuropneumoniae.
    Hart FJ; Kilgore RW; Meinert TR; Nutsch RG; Sunderland SJ; Lechtenberg KF
    Vet Rec; 2006 Apr; 158(13):433-6. PubMed ID: 16581993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-inhibitory concentrations of penicillin G induce biofilm formation by field isolates of Actinobacillus pleuropneumoniae.
    Hathroubi S; Fontaine-Gosselin SÈ; Tremblay YD; Labrie J; Jacques M
    Vet Microbiol; 2015 Sep; 179(3-4):277-86. PubMed ID: 26130517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypic prevalence of apx1V in Actinobacillus pleuropneumoniae field isolates.
    Cho WS; Chae C
    J Vet Diagn Invest; 2001 Mar; 13(2):175-7. PubMed ID: 11289219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 6, serum amyloid A and haptoglobin as markers of treatment efficacy in pigs experimentally infected with Actinobacillus pleuropneumoniae.
    Hultén C; Johansson E; Fossum C; Wallgren P
    Vet Microbiol; 2003 Aug; 95(1-2):75-89. PubMed ID: 12860078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of Actinobacillus (Haemophilus) pleuropneumoniae isolated from pigs with pleuropneumonia.
    Suzuki S; Ohmae K; Ohishi K; Muramatsu M; Takahashi T
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):450-2. PubMed ID: 2739226
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of nontypeable
    To H; Teshima K; Kon M; Yasuda S; Akaike Y; Shibuya K; Nagai S; Sasakawa C
    J Vet Diagn Invest; 2020 Jul; 32(4):581-584. PubMed ID: 32517629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of Actinobacillus pleuropneumoniae serovar 15-like strain from a field case of porcine pleuropneumonia in Japan.
    Koyama T; To H; Nagai S
    J Vet Med Sci; 2007 Sep; 69(9):961-4. PubMed ID: 17917383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular serotyping and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolated from pigs in South Korea.
    Kim B; Hur J; Lee JY; Choi Y; Lee JH
    Vet Q; 2016 Sep; 36(3):137-44. PubMed ID: 26879953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and molecular characterization of a urease-negative Actinobacillus pleuropneumoniae mutant.
    Ito H; Takahashi S; Asai T; Tamura Y; Yamamoto K
    J Vet Diagn Invest; 2018 Jan; 30(1):172-174. PubMed ID: 29145759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.